Anavex Life Sciences Corp (AVXL)

[Hosai]

At the JP morgan conference at minute 31 and for slide 26 Missling stumbles over his words a bit but essentially says this - "we also want to point out the seperation between oral once daily liquid solution for the rare disease franchise, and the oral solid administration for the alzheimers pathology and parkinsons pathology. So we can very nicely seperate those two franchises with different doses aswell as different branding".